Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ANTI-IL12/23 or ANTI-IL23 - risankizumab----1件: 96 💬
2Risankizumab1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬4件: 37, 96, 97, 271 💬
3Risankizumab 10 MG/ML1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
4Risankizumab 180 MG SC1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
5Risankizumab 600 MG IV1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
6Risankizumab 90 MG/ML1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
7Risankizumab IV1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
8Risankizumab SC1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
9Risankizumab-800CW 15 MG1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
10Risankizumab-800CW 25 MG1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
11Risankizumab-800CW 4.5 MG1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
12Risankizumab-800CW optimal dose1件: Risankizumab (Risankizumab)1件: Risankizumab (Risankizumab, Risankizumab, Risankizumab-rzaa) 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬